Literature DB >> 2124639

Postmortem tissue methamphetamine concentrations following selegiline administration.

J E Meeker1, P C Reynolds.   

Abstract

Selegiline is a relatively new antiparkinson's drug whose metabolites include methamphetamine and amphetamine. A 72-year-old female with apparently suicidal intentions was found dead at her residence. The cause of death was listed as coronary heart disease with a history of polypharmacy. The tissue methamphetamine and amphetamine concentrations resulting from selegiline administration are presented in this report.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124639     DOI: 10.1093/jat/14.5.330

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

1.  Biotransformation of deprenyl enantiomers.

Authors:  E Szökö; H Kalász; K Magyar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Oct-Dec       Impact factor: 2.441

2.  In vitro formation of selegiline-N-oxide as a metabolite of selegiline in human, hamster, mouse, rat, guinea-pig, rabbit and dog.

Authors:  Ferenc Lévai; Erzsébet Fejér; Gábor Szeleczky; Anna Szabó; Tünde Eros-Takácsy; Félix Hajdu; Gyula Szebeni; István Szatmári; István Hermecz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jul-Sep       Impact factor: 2.441

Review 3.  Selegiline. A review of its pharmacology, symptomatic benefits and protective potential in Parkinson's disease.

Authors:  P Chrisp; G J Mammen; E M Sorkin
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.